project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 9.0; age at index: 57; days to birth: -21059; days to death: 544; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1948; year of death: 2006; age at diagnosis: 21059; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3153; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-XF-A8HI-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0;